NYSE:EHC - Encompass Health Stock Price, Forecast & News

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Encompass Health announced a quarterly dividend on Friday, October 25th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.28 per share on Wednesday, January 15th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date is Tuesday, December 31st. View Encompass Health's Dividend History.

9 analysts have issued 1 year price targets for Encompass Health's shares. Their forecasts range from $70.00 to $100.00. On average, they anticipate Encompass Health's stock price to reach $83.25 in the next year. This suggests a possible upside of 0.9% from the stock's current price. View Analyst Price Targets for Encompass Health.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 hold rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Encompass Health.

News stories about EHC stock have trended extremely negative recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Encompass Health earned a coverage optimism score of -4.1 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an effect on the stock's share price in the near term. View News Stories for Encompass Health.

Encompass Health saw a increase in short interest in January. As of January 31st, there was short interest totalling 2,470,000 shares, an increase of 26.0% from the January 15th total of 1,960,000 shares. Based on an average trading volume of 625,100 shares, the days-to-cover ratio is currently 4.0 days. Currently, 2.5% of the shares of the company are sold short. View Encompass Health's Current Options Chain.

Some companies that are related to Encompass Health include Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), Healthscope (HSO), Select Medical (SEM), MEDNAX (MD), Magellan Health (MGLN), Primary Health Care (PRY), Capitol Health (CAJ), Medical Facilities (DR), Animalcare Group (ANCR), SunLink Health Systems (SSY) and THC Biomed Intl (THC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Edwards Lifesciences (EW), Axon Enterprise (AAXN), Illumina (ILMN), Mongodb (MDB), Paypal (PYPL), salesforce.com (CRM), Alibaba Group (BABA), Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY) and Adobe (ADBE).

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of EHC stock can currently be purchased for approximately $82.48.

Encompass Health has a market capitalization of $8.13 billion and generates $4.61 billion in revenue each year. The company earns $358.70 million in net income (profit) each year or $3.91 on an earnings per share basis. Encompass Health employs 30,060 workers across the globe.View Additional Information About Encompass Health.

The official website for Encompass Health is http://www.encompasshealth.com/.

Encompass Health's mailing address is 9001 LIBERTY PARKWAY, BIRMINGHAM AL, 35242. The company can be reached via phone at 205-967-7116 or via email at [email protected]